Metastatic Lung Adenocarcinoma Received Combined 177 Lu-FAP-2286 Radiation Therapy and Targeted Therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38598734.
- Also identified by DOI 10.1097/RLU.0000000000005169.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 56-year-old man with metastatic lung adenocarcinoma received combined 177 Lu-FAP-2286 radiation therapy and targeted therapy. After 1 treatment cycle, improvement of symptoms and radiological remission was observed. Moreover, the patient did not report any adverse effects.
Medical subject headings
- Lung Neoplasms
- Adenocarcinoma of Lung